Singapore's national healthtech agency Integrated Health Information Systems (IHiS) has rebranded as Synapxe.
As a part of the rebranding, the agency has unveiled plans under the HealthX platform to accelerate health innovation and AI-powered health solutions for efficient care.
Established early this year, HealthX fosters multi-channels of collaboration amongst government ministries and agencies, industry technology partners, and healthcare providers in the HealthTech space.
Synapxe’s CEO, Ngiam Siew Ying, said the agency will harness technologies including generative AI and cloud for key programmes including Healthier SG, to improve the health of people and ensure a future-ready health system for Singapore.
The agency has developed the nation’s first Assisted Chronic Disease Explanation using AI (ACE-AI) to help general practitioners (GPs) discover personalised insights on patients’ health.
ACE-AI has a prediction accuracy of about 85 percent, said Synapxe.
It will be piloted by the end of 2023 with 20 GPs in support of Healthier SG.
Using a deep learning algorithm, it will identify risk factors and automate risk calculations to detect early signs and risks of chronic diseases, the agency said.
This will assist doctors with chronic disease management of patients, it added.
AI for diagnosis and medication
Along with SingHealth and NTT Data, Synapxe has developed AIM.SG, an AI-powered medical imaging diagnostics platform, allowing integration of AI imaging models from diverse sources across various imaging modalities.
According to Synapxe, the model automates the analysis of medical images with speed and precision for urgent care requirements of patients and assists radiologists in generating radiology reports.
This platform will be piloted at Changi General Hospital and Singapore General Hospital, it added.
The healthtech agency has co-developed Augmented Video Analytics for Medication Adherence (AV-MED), with the National Healthcare Group Polyclinics to assist patients in adhering to medication regimens.
The prototype deploys object detection AI modelling and video analytics to capture the patient’s consumption of medication.
According to the agency, it plans to adapt the technology to support use cases in home care and chronic or infectious disease treatment.
